Clinical application of the molecular diagnosis of spinal muscular atrophy: Deletions of neuronal apoptosis inhibitor protein and survival motor neuron genes

American Journal of Medical Genetics

Volumn 69, Issue 2, 1997, Pages 159-165

  Somerville, Martin J ^a,c   Hunter, Alasdair G W ^a   Aubry, Huguette L ^a   Korneluk, Robert G ^a,b   MacKenzie, Alex E ^b   Surh, Linda C ^a  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

disease risk calculations; NAIP; SMA; SMN

Indexed keywords

INHIBITOR PROTEIN;

ARTICLE; BAYES THEOREM; EXON; GENETIC RISK; GENOTYPE; MOLECULAR GENETICS; PRIORITY JOURNAL; SPINAL MUSCULAR ATROPHY;

CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DNA MUTATIONAL ANALYSIS; EXONS; HUMANS; MUSCULAR ATROPHY, SPINAL; MUTATION; NERVE TISSUE PROTEINS; NEURONAL APOPTOSIS-INHIBITORY PROTEIN; PEDIGREE; POLYMERASE CHAIN REACTION; RNA-BINDING PROTEINS; SEQUENCE DELETION;

EID: 0031049562     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19970317)69:2<159::AID-AJMG8>3.0.CO;2-K     Document Type: Article

References (19)

1. Aubry HL, MacKenzie AE, Surh LC (1995): Delineating the mutations in spinal muscular atrophy: Improved molecular detection and genotype-phenotype correlations. Am J Hum Genet 57(Suppl.): A234.
2. Burd L, Short SK, Martsolf JT, Nelson RA (1991): Prevalence of type I spinal muscular atrophy in north Dakota. Am J Med Genet 41:212-215.
3. Burlet P, Bürglen L, Clermont O, Lefebvre S, Viollet L, Munnich A, Melki J (1996): Large scale deletions of the 5q13 region are specific to Werdnig-Hoffmann disease. J Med Genet 33: 281-283.
4. Cobben JM, Van Der Steege G, Grootscholten P, De Visser M, Scheffer H, Buys CHCM (1995): Deletions of the survival motor neuron (SMN) gene in unaffected siblings of patients with spinal muscular atrophy (SMA). Am J Hum Genet 57:805-808.
5. Crawford TO, Pardo CA (1996): The neurobiology of childhood spinal muscular atrophy. Neurobiol Dis 3:97-110.
6. Dubowitz V (1964): Infantile muscular atrophy - a prospective study with particular reference to a slowly progressive variety. Brain 87:707-718.
7. Dubowitz V (1980): "The Floppy Infant." (2nd ed.) Lavenham, Suffolk, UK: The Lavenham Press Ltd.
8. Emery AEH (1991): Population frequencies of inherited neuromuscular diseases - a world survey. Neuromusc Dis 1:19-29.
9. Hahnen E, Forkert R, Marke C, Schöneborn Sr, Schönling J, Zerres K, Wirth B (1995): Molecular analysis of candidate genes on chromosome 5q13 in autosomal recessive spinal muscular atrophy: Evidence of homozygous deletions of the SMN gene in unaffected individuals. Hum Mol Genet 4:1927-1933.
10. Lefebvre S, Bürglen L, Reboullet S, Clermont O, Burlet P, Viollet L, Benichou B, Cruard C, Millasseau P, Zeviani M, Le Paslier D, Weissenbach J, Munnich A, Melki J (1995): Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80:155-165.
11. Liston P, Roy N, Tamai K, Lefebvre C, Baird S, Horvat GC-, Farahani R, McLean M, Ikeda J-E, Mackenzie A, Korneluk RG (1996): Suppression of apoptosis in mamalian cells by NAIP and a related family of IAP genes. 379:349-353.
12. Nakahori Y, Hamano K, Iwaya M, Nakagome Y (1991): Sex identification by polymerase chain reaction using X-Y homologous primers. Am J Med Genet 39:472-473.
13. Pearn J (1978): Incidence, prevalence, and gene frequency studies of chronic childhood spinal muscular atrophy. J Med Genet 15:409-413.
14. Rodrigues NR, Owen N, Talbot K, Ignatius J, Dubowitz V, Davies KE (1995): Deletions in the survival motor neuron gene on 5q13 in autosomal recessive spinal muscular atrophy. Hum Mol Genet 4:631-634.
15. Roy N, Mahadevan MS, McLean M, Shutler G, Yaraghi Z, Farahani R, Baird S, Johnston AB-, Lefebvre C, Kang X, Salih M, Aubry H, Tamai K, Guan X, Ioannou P, Crawford TO, de Jong PJ, Surh L, Ikeda J-E, Korneluk RG, MacKenzie A (1995): The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell 80:167-178.
16. Schöneborn SR, Forkert R, Hahnen E, Wirth B, Zerres K (1996): Clinical spectrum and diagnostic criteria of infantile spinal muscular atrophy: Further delineation on the basis of SMN deletion findings. Neuropediatrics 27:1-8.
17. Somerville MJ, Mahadevan MS, Korneluk RG, MacKenzie AE, Surh LC (1995): Dosage of candidate genes and severity of spinal muscular atrophy. Am J Hum Genet 57(Suppl.): A251.
18. T) gene deletions in assymptomatic carriers of spinal muscular atrophy. Hum Mol Genet 5:359-365.
19. Zerres K, Schöneborn SR (1995): Natural history in proximal spinal muscular atrophy. Arch Neurol 52:518-523.